Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02892994 · ClinicalTrials.gov registry record · NA

Immediate Effect of Ultrasound Therapy on Bilateral Masseter Myalgia

A NA study, sponsored by State University of New York at Buffalo.

Completed
Registry status
NA
Development phase
23
Enrollment target

NCT02892994 is a NA study that has completed, run by State University of New York at Buffalo. The registered enrollment target is 23 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02892994, a NA study, has completed, sponsored by State University of New York at Buffalo.

COMPLETED
Registry status
NA
Development phase
23 participants
Enrollment target

Study Summary

This study will compare ultrasound 0.4 W/cm\^2 and 100% duty cycle versus no ultrasound (placebo) for bilateral masseter myalgia in up to 38 adult women. The dose will be applied for 5 minutes on each side. Both the dose and the starting side will be randomized. Both the subject and ultrasound operator will be blind to the dose. The outcome measures will be pressure pain threshold on both masseter muscles and both temporalis muscles, self reported pain scale (0, no pain to 10, worst pain ever), thermographic temperature of the muscles, and intraoral temperature. These outcome measures will be taken before and after each dose, so three times per subject.

Interventions

  • OTHER ultrasound

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2016-04
Est. Completion 2016-06
Phase NA

What the Registry Record Tells You About NCT02892994

The ClinicalTrials.gov registry entry for NCT02892994 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which ultrasound is the first listed.

NCT02892994 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02892994 about?

NCT02892994 is a clinical study titled "Immediate Effect of Ultrasound Therapy on Bilateral Masseter Myalgia". This study will compare ultrasound 0.4 W/cm\^2 and 100% duty cycle versus no ultrasound (placebo) for bilateral masseter myalgia in up to 38 adult women. The dose will be applied for 5 minutes on each side. Both the dose and the starting side will be randomized. Both the subject and ultrasound opera...

What is the current status of trial NCT02892994?

This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2016-04. Estimated completion is 2016-06.

What interventions are being tested in trial NCT02892994?

The interventions under investigation include: ultrasound (OTHER).

Who is sponsoring clinical trial NCT02892994?

This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.